# EDGAR Filing Document

**Accession Number:** 0000935494
**File Stem:** 0000935494-23-000004
**Filing Date:** 2023-1
**Character Count:** 45935
**Document Hash:** 0cf2f99c54b60001041c1677c764ea05
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000935494-23-000004.hdr.sgml**: 20230131

**ACCESSION NUMBER**: 0000935494-23-000004

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230131

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Cost Associated with Exit or Disposal Activities

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230131

**DATE AS OF CHANGE**: 20230131

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NATIONAL INSTRUMENTS CORP
- **CENTRAL INDEX KEY:** 0000935494
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **IRS NUMBER:** 741871327
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41595
- **FILM NUMBER:** 23572504

**BUSINESS ADDRESS:**
- **STREET 1:** 11500 NORTH MOPAC EXPRESSWAY
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78759
- **BUSINESS PHONE:** 5123389119

**MAIL ADDRESS:**
- **STREET 1:** 11500 NORTH MOPAC EXPRESSWAY
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78759

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NATIONAL INSTRUMENTS CORP /DE/
- **DATE OF NAME CHANGE:** 19950113

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549
____________________

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of

#### The Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported):

#### January 31, 2023
____________________

## National Instruments Corporation
(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware**<br>| **000-25426**<br>| **74-1871327**<br>|
| (State or other jurisdiction <br> of incorporation) | (Commission <br> File Number) | (IRS Employer <br> Identification No.) |

---

#### 11500 North Mopac Expressway

#### Austin, Texas 78759
(Address of principal executive offices, including zip code)

(512) 683-0100

(Registrant's telephone number, including area code)

#### N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.01 par value | NATI | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 2.02** | **Results of Operations and Financial Condition.** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Attached hereto as Exhibit 99.1 and incorporated by reference herein is the text of the press release of National Instruments Corporation ("NI"), dated January 31, 2023, regarding the unaudited financial results for NI's fourth fiscal quarter and year ended December 31, 2022.

The information in the press release attached hereto as Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

---

| | |
|:---|:---|
| **Item 2.05** | **Costs Associated with Exit or Disposal Activities.** |

---

On January 31, 2023, NI announced a workforce reduction plan (the "Plan") intended to accelerate its growth strategy and further optimize its operations and cost structure. The Plan is expected to reduce NI's worldwide headcount by approximately 4% during 2023, with a majority of the reductions expected to occur in the first quarter of 2023.

In connection with the Plan, NI estimates that it will recognize pre-tax charges to its GAAP financial results of approximately $20 million to $25 million, consisting primarily of cash termination benefits and other employee-related costs that are expected to be paid in 2023. NI anticipates that the majority of these charges will be recognized during the first quarter of 2023, with the remaining amount expected to be recognized during 2023.

This Current Report on Form 8-K contains forward-looking statements which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include the size of the restructuring and the amount and timing of the related charges. Statements regarding future events are based on NI's current expectations and are necessarily subject to associated risks related to the completion of the restructuring in the manner anticipated by NI. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due to a variety of factors, including: NI's ability to achieve the benefits of the announced restructuring and possible changes in the size and timing of the related charges. For information regarding other factors that could cause NI's results to vary from expectations, please see the "Risk Factors" section of NI's filings with the Securities and Exchange Commission. NI undertakes no obligation to revise or update publicly any forward-looking statements.

---

| | |
|:---|:---|
| **Item 8.01** | **Other Events.** |

---

On January 31, 2023, NI issued a press release announcing that its Board of Directors declared a dividend of $0.28 per share payable on March 6, 2023 to stockholders of record at the close of business on February 13, 2023.

A copy of the press release announcing the dividend is attached hereto as Exhibit 99.1.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits** |

---

(d) Exhibits.

<u>Exhibit No.</u> <u>Description</u> <br> 99.1 [Press Release, dated January 31, 2023](exhibit99_1.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | **NATIONAL INSTRUMENTS CORPORATION** |
| By: | /s/ R. Eddie Dixon, Jr. |
|  | Name: R. Eddie Dixon, Jr.<br> Title: Chief Legal Officer, Senior Vice President & Secretary |

---

Date: January 31, 2023

## Exhibit 99.1

**Contact:** Marissa Vidaurri

Vice President of Investor Relations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(512) 683-5215

#### NI Achieves Record Revenue for Q4 and Fiscal Year 2022

#### Company's transformation continues to deliver improved operating performance

#### Q4 2022 Highlights
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• All-time record revenue of $448 million, up 7 percent year over year

&nbsp;&nbsp;&nbsp;&nbsp;• Q4 GAAP operating margin of 13 percent; Q4 non-GAAP operating margin of 25 percent

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Strong diluted GAAP EPS of $0.30; all-time record diluted non-GAAP EPS of $0.63

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash and cash equivalents of $140 million as of December 31, 2022

**AUSTIN, Texas - January 31, 2023 -** National Instruments Corporation (Nasdaq: NATI) today announced Q4 2022 revenue of $448 million, up 7 percent year over year and an all-time quarterly record.

In Q4 2022, the value of the company's total orders was down 3 percent year over year. Geographic order growth for Q4 2022 compared with Q4 2021 was down 7 percent in the Americas, down 9 percent in APAC and up 7 percent in EMEA.

In Q4, GAAP gross margin was 68 percent and non-GAAP gross margin was 70 percent. Total Q4 GAAP operating expenses were $244 million, down 1 percent year over year. Total Q4 non-GAAP operating expenses were $201 million, down 6 percent year over year. GAAP operating margin was 13 percent in Q4, with GAAP operating income of $60 million, up 21 percent year over year. Non-GAAP operating margin was 25 percent in Q4, with non-GAAP operating income of $112 million, up 16 percent year over year.

GAAP net income for Q4 was $40 million, with diluted earnings per share ("EPS") of $0.30, and non-GAAP net income was $83 million, with non-GAAP diluted EPS of $0.63.

"2022 was a strong year as we continued to make strides in transforming NI into a higher-growth, more profitable, and more resilient company. Despite ongoing global macroeconomic uncertainty, we delivered on the 2022 targets we shared at our September investor conference with record revenue of $1.7 billion, up 13 percent YOY, and non-GAAP operating margin of 20 percent, up 130 bps as compared to 2021," said Eric Starkloff, NI president and CEO. "As we head into 2023, even in a recessionary environment, we now expect to exceed our 300 bps non-GAAP margin expansion target."

"In my first few weeks at NI, I've been impressed with the high level of talent in the organization, as well as the NI culture of engineering and commitment to its customers," said Daniel Berenbaum, NI CFO. "My focus will be on accelerating operational improvements to achieve our margin targets, improving working capital management and cash flow generation, and building investor confidence in our ability to execute. We have already undertaken a number of initiatives which underpin our confidence in being able to generate significant operating margin improvement in 2023."

NI's non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange gain/loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings/assets and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of NI's GAAP and non-GAAP results are included as part of this news release.

#### FY 2022 Highlights

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• All-time record revenue of $1.66 billion, up 13 percent year over year

&nbsp;&nbsp;&nbsp;&nbsp;• GAAP operating margin of 12 percent; Non-GAAP operating margin of 20 percent

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Strong diluted GAAP EPS of $1.05; record diluted non-GAAP EPS of $1.93

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Returned $300 million to stockholders through dividends and stock repurchases

In 2022, GAAP operating expenses were $964 million, up 4 percent year over year, and non-GAAP operating expenses were $836 million, up 1 percent year over year. GAAP net income in 2022 was $140 million, up 56 percent year over year, and non-GAAP net income was $255 million, up 14 percent year over year.

As of December 31, 2022, NI had $140 million in cash with $43 million in cash generated from operations in 2022. During Q4, NI paid $37 million in dividends. For the year, we returned $300 million to our stockholders through dividends and stock repurchases, including the repurchase of 3.8 million shares at an average price of $40.04 per share. The NI Board of Directors approved a dividend of $0.28 per share payable on March 6, 2023, to stockholders of record at the close of business on February 13, 2023.

#### Q1 2023 Guidance
&nbsp;&nbsp;&nbsp;&nbsp;• GAAP revenue to be in the range of $415 million to $445 million, up 12 percent year over year at the midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP diluted EPS to be in the range of $0.14 to $0.28, up 2 cents year over year at the midpoint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP diluted EPS expected to be in the range of $0.48 to $0.62, up 34 percent year over year at the midpoint

#### Conference Call Information
Today, NI management will host a call with the investment community to discuss the company's financial performance in the fourth quarter. Investors can listen to the Q4 2022 earnings conference call beginning at 4:00 p.m. CT today. This event will be webcast in listen-only mode. Listeners may log on to the call at www.ni.com/investor-relations under the "Events and Presentations" section and select "Q4 2022 NATI Earnings Conference Call" to participate. The webcast will remain on the company site for 90 days.

#### Non-GAAP Presentation
To supplement NI's financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including non-GAAP revenue or net sales, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin and diluted EPS and non-GAAP guidance for diluted EPS. A reconciliation of the adjustments to GAAP results is included in the tables below. Additionally, certain non-GAAP financial measures presented on a forward-looking basis, such as non-GAAP operating margin, were not reconciled to the comparable GAAP financial measures because the reconciliation could not be performed without unreasonable efforts due to the unpredictability of the amounts and timing of events affecting the items we exclude from non-GAAP measures. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.

#### Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 including without limitation those statements about our expectations of accelerating growth and progress to meet or exceed our financial targets and long-term financial model, our continued momentum across regions and business units, our opportunities to drive growth, profitability and efficiency in our business, confidence in our strategy and the strategic changes made to our business, our ability to successfully integrate acquisitions and execute our growth strategy, our ability to turn backlog to revenue, our ability to drive customer demand through focus on high growth opportunities, the impacts of war in Europe, supply chain constraints and software licensing model transition on our financial results, the outcome of the Company's restructuring activities and strategic alternatives process and our guidance and expectations for our Q1 2023 revenue, diluted EPS and non-GAAP diluted EPS, and future operating expenses, backlog, lead times, gross margin, operating margin and tax rate. These statements are subject to a number of risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the global shortage of key components; effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively manage our partners and distribution channels; interruptions in our technology systems or cyber-attacks on our systems; the dependency of our product revenue on certain industries and the risk of contractions in such industries; concentration of credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; longer delivery lead times from our suppliers; risk of product liability claims; dependence on our proprietary rights and risks of intellectual property litigation; the continued service of key management, technical personnel and operational employees; our ability to comply with environmental laws and associated costs; our ability to maintain our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our restructuring activities; our exposure to large orders; our shift to more system orders; our ability to effectively manage our operating expenses and meet budget; fluctuations in our quarterly results due to factors outside of our control; our outstanding debt; the interest rate risk associated with our variable rate indebtedness; seasonal variation in our revenues; our ability to comply with laws and regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships; risks related to currency fluctuations; provisions in charter documents and Delaware law that delay or prevent our acquisition; and risks related to our strategic review process. In addition, our ability to declare and/or pay declared dividends is subject to compliance with the terms of our existing credit agreement. The company directs readers to its Form 10-K for the year ended December 31, 2021, its subsequent Form 10-Qs, and the other documents it files with the SEC for other risks associated with the company's future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements. All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

#### About NI
At NI, we bring together people, ideas and technology so forward thinkers and creative problem solvers can take on humanity's biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

*National Instruments, NI, <u>ni.com</u> and Engineer Ambitiously are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies. (NATI-F)*

------

---

| | | |
|:---|:---|:---|
| **National Instruments** | **National Instruments** | **National Instruments** |
| **Condensed Consolidated Balance Sheets** | **Condensed Consolidated Balance Sheets** | **Condensed Consolidated Balance Sheets** |
| **(in thousands)** | **(in thousands)** | **(in thousands)** |
|  | **December 31,** | **December 31,** |
|  | **2022** | **2021** |
|  | (unaudited)  |  |
| ASSETS |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Cash and cash equivalents | $139799 | $211106 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable, net | 445279 | 341275 |
| &nbsp;&nbsp;&nbsp;&nbsp; Inventories, net | 388164 | 289243 |
| &nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other current assets | 115677 | 89925 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current assets | 1088919 | 931549 |
| Property and equipment, net | 265380 | 253668 |
| Goodwill | 615734 | 575992 |
| Intangible assets, net | 200850 | 220418 |
| Operating lease right-of-use assets | 59176 | 58641 |
| Other long-term assets | 128479 | 74717 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | 2358538 | 2114985 |
| LIABILITIES AND EQUITY |  |  |
| &nbsp;&nbsp; Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accounts payable (1) | 54639 | 59063 |
| &nbsp;&nbsp;&nbsp;&nbsp; Accrued compensation | 71422 | 111261 |
| &nbsp;&nbsp;&nbsp;&nbsp; Deferred revenue | 137208 | 137818 |
| &nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities | 13834 | 13137 |
| &nbsp;&nbsp;&nbsp;&nbsp; Other taxes payable | 67615 | 59109 |
| &nbsp;&nbsp;&nbsp;&nbsp; Debt - current | 25000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses and other current liabilities (1) | 153157 | 64826 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities | 522875 | 445214 |
| Debt - non-current | 516637 | 300000 |
| Deferred income taxes | 1676 | 14249 |
| Income tax payable - non-current | 40646 | 54195 |
| Deferred revenue - non-current | 63066 | 32822 |
| Operating lease liabilities - non-current | 30588 | 30468 |
| Other long-term liabilities | 26926 | 14340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 1202414 | 891288 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp; Preferred stock |  |  |
| &nbsp;&nbsp; Common stock | 1310 | 1323 |
| &nbsp;&nbsp; Additional paid-in capital | 1207420 | 1129647 |
| &nbsp;&nbsp; Retained (deficit) earnings | (14741) | 112858 |
| &nbsp;&nbsp; Accumulated other comprehensive loss | (37865) | (20131) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total stockholders' equity | 1156124 | 1223697 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities and stockholders' equity | $2358538 | $2114985 |

---

(1): In the fourth quarter 2022, we reclassified $26.9 million of accrued liability balances from "Accounts payable" to "Accrued expenses and other current liabilities." To conform with the current period presentation, the following amounts reported in previous periods have also been reclassified: $25.6 million at September 30, 2022, $29.8 million at June 30, 2022, $23.2 million at March 31, 2022, and $24.2 million at December 31, 2021.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **National Instruments** | **National Instruments** | **National Instruments** | **National Instruments** | **National Instruments** |
| **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** | **Condensed Consolidated Statements of Income** |
| **(in thousands, except per share data, unaudited)** | **(in thousands, except per share data, unaudited)** | **(in thousands, except per share data, unaudited)** | **(in thousands, except per share data, unaudited)** | **(in thousands, except per share data, unaudited)** |
|  | **Three Months Ended** | **Three Months Ended** | **Years Ended** | **Years Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| Net sales: |  |  |  |  |
| &nbsp;&nbsp; Product | $412607 | $377303 | $1500716 | $1304609 |
| &nbsp;&nbsp; Software maintenance | 35669 | 43338 | 156259 | 165072 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total net sales | 448276 | 420641 | 1656975 | 1469681 |
| Cost of sales: |  |  |  |  |
| &nbsp;&nbsp; Product | 139700 | 119857 | 517854 | 406342 |
| &nbsp;&nbsp; Software maintenance | 4621 | 3739 | 16870 | 14621 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total cost of sales | 144321 | 123596 | 534724 | 420963 |
| Gross profit | 303955 | 297045 | 1122251 | 1048718 |
|  | *68%* | *71%* | *68%* | *71%* |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp; Sales and marketing | 118252 | 122304 | 483267 | 467352 |
| &nbsp;&nbsp; Research and development | 81100 | 92301 | 331710 | 335986 |
| &nbsp;&nbsp; General and administrative | 44272 | 32543 | 148841 | 127215 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total operating expenses | 243624 | 247148 | 963818 | 930553 |
| Gain on sale of assets |  |  | 33636 |  |
| Operating income | 60331 | 49897 | 192069 | 118165 |
| Other income (expense) | (11571) | (4739) | (20193) | (14590) |
| Income before income taxes | 48760 | 45158 | 171876 | 103575 |
| Provision for income taxes | 8694 | 4822 | 32232 | 14260 |
| Net income | $40066 | $40336 | $139644 | $89315 |
| Basic earnings per share | $0.31 | $0.31 | $1.06 | $0.68 |
| Diluted earnings per share | $0.30 | $0.30 | $1.05 | $0.67 |
| Weighted average shares outstanding - |  |  |  |  |
| Basic | 130842 | 132215 | 131738 | 132311 |
| Diluted | 131746 | 133225 | 132533 | 133562 |
| Dividends declared per share | $0.28 | $0.27 | $1.12 | $1.08 |

---

------

---

| | | |
|:---|:---|:---|
| **National Instruments** | **National Instruments** | **National Instruments** |
| **Condensed Consolidated Statements of Cash Flows** | **Condensed Consolidated Statements of Cash Flows** | **Condensed Consolidated Statements of Cash Flows** |
| **(in thousands)** | **(in thousands)** | **(in thousands)** |
|  | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2022** | **2021** |
|  | (unaudited) |  |
| **Cash flow from operating activities:** |  |  |
| Net income | $139644 | $89315 |
| &nbsp;&nbsp; Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and amortization | 90707 | 99402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stock-based compensation | 78615 | 74583 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disposal gain on sale of business/asset | (33636) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss from equity-method investees | 163 | 5719 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income taxes | (71590) | (15796) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net change in operating assets and liabilities | (160939) | (109724) |
| **Net cash provided by operating activities** | 42964 | 143499 |
| **Cash flow from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Acquisitions, net of cash received | (72319) | (223080) |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sale of assets/business, net of cash divested | 40987 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Capital expenditures | (48193) | (40975) |
| &nbsp;&nbsp;&nbsp;&nbsp; Capitalization of internally developed software | (388) | (1463) |
| &nbsp;&nbsp;&nbsp;&nbsp; Additions to other intangibles | (3558) | (2751) |
| &nbsp;&nbsp;&nbsp;&nbsp; Acquisitions of equity-method and other investments |  | (15753) |
| &nbsp;&nbsp;&nbsp;&nbsp; Sales and maturities of short-term investments |  | 60297 |
| **Net cash used by investing activities** | (83471) | (223725) |
| **Cash flow from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from term loan | 500000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Payments of term loan | (6250) | (98750) |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from revolving line of credit | 268000 | 300000 |
| &nbsp;&nbsp;&nbsp;&nbsp; Payments of revolving line of credit | (518000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Debt issuance costs | (2348) | (1993) |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from issuance of common stock | 31815 | 32518 |
| &nbsp;&nbsp;&nbsp;&nbsp; Repurchase of common stock | (151830) | (55000) |
| &nbsp;&nbsp;&nbsp;&nbsp; Dividends paid | (147835) | (143113) |
| **Net cash provided by (used by) financing activities** | (26448) | 33662 |
| **Impact of changes in exchange rates on cash** | (4352) | (2562) |
| **Net change in cash and cash equivalents** | (71307) | (49126) |
| Cash and cash equivalents at beginning of period | 211106 | 260232 |
| Cash and cash equivalents at end of period | $139799 | $211106 |

---

------

**The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction costs, disposal gains on sale of business/assets and related charitable contributions, tax effects related to businesses held-for-sale, capitalization and amortization of internally developed software costs, and restructuring charges that were recorded in the line items indicated below (unaudited) (in thousands):**

#### <br>

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended | Three Months Ended | Years Ended | Years Ended |
|  | December 31, | December 31, | December 31, | December 31, |
|  | 2022 | 2021 | 2022 | 2021 |
| Stock-based compensation |  |  |  |  |
| Cost of sales | $884 | $1092 | $4658 | $4580 |
| Sales and marketing | 4991 | 6284 | 26430 | 25233 |
| Research and development | 6034 | 5811 | 24556 | 23515 |
| General and administrative | 5862 | 5335 | 22970 | 21384 |
| Provision for income taxes | (2418) | (2010) | (10105) | (12047) |
| Total | $15353 | $16512 | $68509 | $62665 |
| Amortization of acquisition-related intangibles and fair value adjustments |  |  |  |  |
| Net sales | $254 | $352 | $1367 | $2324 |
| Cost of sales | 5878 | 6700 | 22903 | 19391 |
| Sales and marketing | 4955 | 3334 | 22379 | 10192 |
| Research and development |  | 320 | (320) | 320 |
| Other expense (income) | 467 | 531 | 1968 | 2007 |
| Provision for income taxes | (1705) | (1626) | (7507) | (4071) |
| Total | $9849 | $9611 | $40790 | $30163 |
| Acquisition-related transaction and integration costs, restructuring charges, and other(1)(2) |  |  |  |  |
| Net sales | $— | $— | $(411) | $— |
| Cost of sales | 1270 | 25 | 9819 | (25) |
| Sales and marketing | 7014 | 1687 | 12478 | 7759 |
| Research and development | 2422 | 9682 | 3977 | 11104 |
| General and administrative (2) | 11068 | 865 | 15547 | 8254 |
| Gain on sale of asset (2) |  |  | (33636) |  |
| Other expense (income) (1) | (400) |  | (5685) | 4322 |
| Provision for income taxes | (4433) | (2708) | 60 | (6837) |
| Total | $16941 | $9551 | $2149 | $24577 |
| (1): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments. | (1): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments. | (1): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments. | (1): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments. | (1): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method investments. |
| (2): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets". The company also recognized a charitable contribution expense of $10 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative". | (2): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets". The company also recognized a charitable contribution expense of $10 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative". | (2): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets". The company also recognized a charitable contribution expense of $10 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative". | (2): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets". The company also recognized a charitable contribution expense of $10 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative". | (2): During the third quarter of 2022, the company recognized a gain of $34 million related to the sale of land and office buildings, presented within "Gain on sale of assets". The company also recognized a charitable contribution expense of $10 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative". |
| (Capitalization) and amortization of internally developed software costs |  |  |  |  |
| Cost of sales | $773 | $5041 | $5863 | $23674 |
| Research and development |  | (188) | (388) | (1433) |
| Provision for income taxes | (179) | (1085) | (1238) | (4877) |
| Total | $594 | $3768 | $4237 | $17364 |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **National Instruments** | **National Instruments** | **National Instruments** | **National Instruments** | **National Instruments** |
| **Reconciliation of GAAP to Non-GAAP Measures** | **Reconciliation of GAAP to Non-GAAP Measures** | **Reconciliation of GAAP to Non-GAAP Measures** | **Reconciliation of GAAP to Non-GAAP Measures** | **Reconciliation of GAAP to Non-GAAP Measures** |
| **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** | **(in thousands, unaudited)** |
|  | **Three Months Ended** | **Three Months Ended** | **Years Ended** | **Years Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| **Reconciliation of Gross Profit to Non-GAAP Gross Profit** |  |  |  |  |
| **Gross profit, as reported** | $303955 | $297045 | $1122251 | $1048718 |
| &nbsp;&nbsp; Stock-based compensation | 884 | 1092 | 4658 | 4580 |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | 6132 | 7052 | 24270 | 21715 |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | 1270 | 25 | 9408 | $(25) |
| &nbsp;&nbsp; Amortization of internally developed software costs | 773 | 5041 | 5863 | 23674 |
| **Non-GAAP gross profit** | $313014 | $310255 | $1166450 | $1098662 |
| *Non-GAAP gross margin* | *70%* | *74%* | *70%* | *75%* |
| **Reconciliation of Operating Expenses to Non-GAAP Operating Expenses** | **Reconciliation of Operating Expenses to Non-GAAP Operating Expenses** | **Reconciliation of Operating Expenses to Non-GAAP Operating Expenses** |  |  |
| **Operating expenses, as reported** | $243624 | $247148 | $963818 | $930553 |
| &nbsp;&nbsp; Stock-based compensation | (16887) | (17430) | (73956) | (70132) |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | (4955) | (3654) | (22059) | (10512) |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | (20504) | (12234) | (32002) | (27117) |
| &nbsp;&nbsp; Capitalization of internally developed software costs |  | 188 | 388 | 1433 |
| **Non-GAAP operating expenses** | $201278 | $214018 | $836189 | $824225 |
| **Reconciliation of Operating Income to Non-GAAP Operating Income** | **Reconciliation of Operating Income to Non-GAAP Operating Income** | **Reconciliation of Operating Income to Non-GAAP Operating Income** |  |  |
| **Operating income, as reported** | $60331 | $49897 | $192069 | $118165 |
| &nbsp;&nbsp; Stock-based compensation | 17771 | 18522 | 78614 | 74712 |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | 11087 | 10706 | 46329 | 32227 |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | 21774 | 12259 | 41410 | 27092 |
| &nbsp;&nbsp; Net amortization of internally developed software costs | 773 | 4853 | 5475 | 22241 |
| &nbsp;&nbsp; Gain on sale of business/assets |  |  | (33636) |  |
| **Non-GAAP operating income** | $111736 | $96237 | $330261 | $274437 |
| *Non-GAAP operating margin* | *25%* | *23%* | *20%* | *19%* |
| **Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes** | **Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes** | **Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes** |  |  |
| **Provision for income taxes, as reported<sup>(1)</sup>** | $8694 | $4822 | $32232 | $14260 |
| &nbsp;&nbsp; Stock-based compensation | 2418 | 2010 | 10105 | 12047 |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | 1705 | 1626 | 7507 | 4071 |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | 4433 | 2708 | 6378 | 6837 |
| &nbsp;&nbsp; Net amortization of internally developed software costs | 179 | 1085 | 1238 | 4877 |
| &nbsp;&nbsp; Gain on sale of business/assets |  |  | (6438) |  |
| **Non-GAAP provision for income taxes<sup>(1)</sup>** | $17429 | $12251 | $51022 | $42092 |
| (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS** | **Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS** | **Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS** | **Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS** | **Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS** |
| **(in thousands, except per share data, unaudited)**<br> **** | **(in thousands, except per share data, unaudited)**<br> **** | **(in thousands, except per share data, unaudited)**<br> **** | **(in thousands, except per share data, unaudited)**<br> **** | **(in thousands, except per share data, unaudited)**<br> **** |
|  | **Three Months Ended** | **Three Months Ended** | **Years Ended** | **Years Ended** |
|  | **December 31,** | **December 31,** | **December 31,** | **December 31,** |
|  | **2022** | **2021** | **2022** | **2021** |
| **Net income, as reported** | $40066 | $40336 | $139644 | $89315 |
| *Adjustments to reconcile net income to non-GAAP net income:* |  |  |  |  |
| &nbsp;&nbsp; Stock-based compensation | 17771 | 18522 | 78614 | 74712 |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | 11554 | 11237 | 48297 | 34234 |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | 21374 | 12259 | 35725 | 31414 |
| &nbsp;&nbsp; Net amortization of internally developed software costs | 773 | 4853 | 5475 | 22241 |
| &nbsp;&nbsp; Gain on sale of business/asset |  |  | (33636) |  |
| &nbsp;&nbsp; Income tax effects and adjustments<sup>(1)</sup> | (8735) | (7429) | (18790) | (27832) |
| **Non-GAAP net income** | $82803 | $79778 | $255329 | $224084 |
| &nbsp;&nbsp;&nbsp;&nbsp; *Non-GAAP net margin* | 18.5% | 18.9% | 15.4% | 15.2% |
| **Diluted EPS, as reported** | $0.30 | $0.30 | $1.05 | $0.67 |
| Adjustment to reconcile diluted EPS to non-GAAP diluted EPS |  |  |  |  |
| &nbsp;&nbsp; Stock-based compensation | 0.14 | 0.14 | 0.59 | 0.56 |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | 0.09 | 0.09 | 0.37 | 0.26 |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | 0.16 | 0.09 | 0.27 | 0.23 |
| &nbsp;&nbsp; Net amortization of internally developed software costs | 0.01 | 0.04 | 0.04 | 0.17 |
| &nbsp;&nbsp; Gain on sale of business/asset |  |  | (0.25) |  |
| &nbsp;&nbsp; Income tax effects and adjustments<sup>(1)</sup> | (0.07) | (0.06) | (0.14) | (0.21) |
| **Non-GAAP diluted EPS** | $0.63 | $0.60 | $1.93 | $1.68 |
| (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |
| **Weighted average shares outstanding** |  |  |  |  |
| &nbsp;&nbsp; Basic | 130842 | 132215 | 131738 | 132311 |
| &nbsp;&nbsp; Diluted | 131746 | 133225 | 132533 | 133562 |

---

---

| | | |
|:---|:---|:---|
| **Reconciliation of GAAP Diluted EPS Guidance to Non-GAAP Diluted EPS Guidance** | **Reconciliation of GAAP Diluted EPS Guidance to Non-GAAP Diluted EPS Guidance** | **Reconciliation of GAAP Diluted EPS Guidance to Non-GAAP Diluted EPS Guidance** |
| (unaudited) | (unaudited) | (unaudited) |
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2023** | **March 31, 2023** |
|  | **Low** | **High** |
| **GAAP Diluted EPS, guidance** | $0.14 | $0.28 |
| *Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:* |  |  |
| &nbsp;&nbsp; Stock-based compensation | 0.14 | 0.14 |
| &nbsp;&nbsp; Amortization of acquisition-related intangibles and fair value adjustments | 0.08 | 0.08 |
| &nbsp;&nbsp; Acquisition transaction and integration costs, restructuring charges and other | 0.19 | 0.19 |
| &nbsp;&nbsp; Net amortization of internally developed software costs |  |  |
| &nbsp;&nbsp; Income tax effects and adjustments<sup>(1)</sup> | (0.07) | (0.07) |
| **Non-GAAP Diluted EPS, guidance** | $0.48 | $0.62 |
| (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. | (1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments. |

---

<br>